NCT02124018

Brief Summary

The purpose of the study is to assess the prevalence and the prognostic value of non-invasive indexes and programmed ventricular stimulation for sudden cardiac death in post-myocardial infarction (MI) patients with left ventricular ejection fraction (LVEF)\>40%.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
575

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 28, 2014

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 26, 2019

Completed
Last Updated

September 4, 2019

Status Verified

August 1, 2019

Enrollment Period

4.3 years

First QC Date

April 24, 2014

Results QC Date

April 16, 2019

Last Update Submit

August 23, 2019

Conditions

Keywords

Myocardial infarctionRisk stratificationSudden cardiac deathPreserved ejection fractionProgrammed ventricular stimulation

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Major Arrhythmic Events (MAEs) - Present When One of the Following Occurred: Sudden Cardiac Death, Sustained Ventricular Tachycardia, or Implantable Cardioverter - Defibrillator (ICD) Activation

    The number of patients from each risk level group meeting the primary endpoint will be used to assess diagnostic accuracy (positive/negative predictive value, sensitivity and specificity) of the proposed two-stage, PVS-inclusive, risk stratification approach for the allocation of an ICD

    From stratification completion (i.e. allocation to one of three risk level groups) until either occurrence of primary endpoint or study completion (mean 32months) - study stopped early due to emergence of clearly defined high risk subgroup

Secondary Outcomes (1)

  • Total Mortality

    From completion of risk stratification to study completion or outcome occurrence (mean 32 months)

Study Arms (1)

Post-MI patients

Asymptomatic post-MI patients late after MI or 40 days after STEMI-NSTEMI with preserved ejection fraction and absence of active ischemia Programmed ventricular stimulation (PVS) will be performed in high-risk patients based on non-invasive evaluation. ICD implantation will be performed in patients with induced ventricular tachycardia (VT) upon PVS

Procedure: Programmed ventricular stimulationDevice: ICD implantation

Interventions

Programmed ventricular stimulation in high-risk patients based on non-invasive evaluation

Post-MI patients

ICD implantation in patients with induced VT in programmed ventricular stimulation

Post-MI patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1000 asymptomatic post-MI patients\>40%, at least 40 days post-MI, revascularized or without needing further revascularization (in any case without any evidence of ischemia) The patients will be divided into two categories: 1. Asymptomatic patients with revascularized STEMI (remaining stenoses in non culprit vessels \<70%) at 40 days post-MI (when LVEF\>40% will be re-assessed) 2. Asymptomatic patients late after MI (initially STEMI-NSTEMI at discharge Q-non Q) with LVEF\>40% right after a negative stress test or right after a negative for stenoses control coronary catheterization

You may qualify if:

  • Asymptomatic patients with revascularized STEMI (remaining stenoses in non culprit vessels \<70%) at 40 days post-MI (when LVEF\>40% will be re-assessed)
  • Asymptomatic patients late after MI (initially STEMI-NSTEMI at discharge Q-non Q) with LVEF\>40% right after a negative stress test or right after a negative for stenoses control coronary catheterization

You may not qualify if:

  • Episodes of sustained VT or aborted sudden cardiac death (SCD) 48 hours after the acute MI phase.
  • Episodes of syncope within the last 6 months
  • Cancer, liver failure (cirrhosis), end-stage renal disease
  • Use of anti-arrhythmic drugs other than b-blockers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Cardiology Clinic, Hippokration Hospital

Athens, 11527, Greece

Location

Related Publications (1)

  • Gatzoulis KA, Tsiachris D, Arsenos P, Antoniou CK, Dilaveris P, Sideris S, Kanoupakis E, Simantirakis E, Korantzopoulos P, Goudevenos I, Flevari P, Iliodromitis E, Sideris A, Vassilikos V, Fragakis N, Trachanas K, Vernardos M, Konstantinou I, Tsimos K, Xenogiannis I, Vlachos K, Saplaouras A, Triantafyllou K, Kallikazaros I, Tousoulis D. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study. Eur Heart J. 2019 Sep 14;40(35):2940-2949. doi: 10.1093/eurheartj/ehz260.

MeSH Terms

Conditions

Myocardial InfarctionDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisHeart ArrestDeath, SuddenDeath

Limitations and Caveats

Study was not a randomized clinical trial since almost all patients with a per protocol indication received a device, without the presence of a high-risk control group, thus potentially overestimating true arrhythmic risk.

Results Point of Contact

Title
Professor Konstantinos A. Gatzoulis
Organization
First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens

Study Officials

  • Konstantinos Gatzoulis, MD, PhD

    University of Athens, Hippokration Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Professor of Cardiology

Study Record Dates

First Submitted

April 24, 2014

First Posted

April 28, 2014

Study Start

April 1, 2014

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

September 4, 2019

Results First Posted

August 26, 2019

Record last verified: 2019-08

Locations